Point72 Asset Management
AGIO icon

Point72 Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Point72 Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Buy
+506,344
New +$15.4M 0.02% 926
2026
Q1 		– Sell
-200,000
Closed -$5.67M – 3728
2025
Q4 		$5.44M Buy
200,000
+193,493
+2,974% +$6.79M 0.01% 1782
2025
Q3 		$261K Buy
+6,507
New +$245K ﹤0.01% 2095
2021
Q2 		– Sell
-101,100
Closed -$5.22M – 953
2021
Q1 		$5.22M Sell
101,100
-78,500
-44% -$3.89M 0.02% 557
2020
Q4 		$7.78M Sell
179,600
-298,252
-62% -$11.8M 0.04% 496
2020
Q3 		$16.7M Buy
477,852
+144,593
+43% +$6.34M 0.09% 308
2020
Q2 		$17.8M Buy
333,259
+202,645
+155% +$9.38M 0.12% 232
2020
Q1 		$4.63M Buy
+130,614
New +$6.04M 0.04% 391
2019
Q3 		– Sell
-6,753
Closed -$337K – 1099
2019
Q2 		$337K Sell
6,753
-105,705
-94% -$5.65M ﹤0.01% 905
2019
Q1 		$7.58M Sell
112,458
-42,542
-27% -$2.48M 0.03% 467
2018
Q4 		$7.15M Sell
155,000
-20,700
-12% -$1.28M 0.03% 473
2018
Q3 		$13.6M Buy
175,700
+20,500
+13% +$1.65M 0.06% 395
2018
Q2 		$13.1M Sell
155,200
-250,890
-62% -$21.9M 0.05% 381
2018
Q1 		$33.2M Buy
406,090
+314,590
+344% +$24.3M 0.14% 190
2017
Q4 		$5.23M Sell
91,500
-38,140
-29% -$2.4M 0.02% 582
2017
Q3 		$8.65M Sell
129,640
-73,360
-36% -$4.41M 0.04% 428
2017
Q2 		$10.4M Buy
203,000
+140,500
+225% +$7.18M 0.06% 380
2017
Q1 		$3.65M Sell
62,500
-37,500
-38% -$1.8M 0.02% 594
2016
Q4 		$4.17M Buy
+100,000
New +$5.25M 0.03% 465
2014
Q3 		– Sell
-46,100
Closed -$2.11M – 633
2014
Q2 		$2.11M Buy
+46,100
New +$1.88M 0.01% 553

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Point72 Asset Management's AGIO Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 506,344 shares worth $18.8M. The stake represents 0.02% of the portfolio and ranks #926 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in AGIO as recently as Q4 2025.

Point72 Asset Management first reported a position in AGIO in Q2 2014 and has held it in 20 quarters since. The position peaked at $33.2M in Q1 2018. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Point72 Asset Management held 506,344 shares of Agios Pharmaceuticals worth $18.8M as of Q2 2026.
  • Agios Pharmaceuticals was a new Point72 Asset Management position in Q2 2026.
  • Agios Pharmaceuticals made up 0.02% of Point72 Asset Management's portfolio in Q2 2026, its #926 holding.
  • Point72 Asset Management first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 20 quarters since.
  • Point72 Asset Management's Agios Pharmaceuticals position peaked at $33.2M in Q1 2018.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.